Comparison between Accretion Pharmaceuticals IPO and B.D.Industries IPO.
Accretion Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while B.D.Industries IPO is a SME Bookbuilding proposed to list at BSE SME.
| Accretion Pharmaceuticals IPO | B.D.Industries IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Jawa Capital Services Pvt.Ltd. | Aryaman Financial Services Ltd. |
| Registrar | Kfin Technologies Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Aryaman Capital Markets Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Accretion Pharmaceuticals IPO is up to ₹28.26 Cr whereas the issue size of the B.D.Industries IPO is up to ₹43.03 Cr. The final issue price of Accretion Pharmaceuticals IPO is ₹101.00 per share and of B.D.Industries IPO is ₹108.00 per share.
| Accretion Pharmaceuticals IPO | B.D.Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹96.00 per share | ₹102.00 per share |
| Issue Price (Upper) | ₹101.00 per share | ₹108.00 per share |
| Issue Price (Final) | ₹101.00 per share | ₹108.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1200 shares |
| Fresh Issue Size | 27,98,400 shares | 39,84,000 shares |
| Fresh Issue Size (Amount) | up to ₹28.26 Cr | up to ₹43.03 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 27,98,400 shares | 39,84,000 shares |
| Issue Size Total (Amount) | up to ₹28.26 Cr | up to ₹43.03 Cr |
Accretion Pharmaceuticals IPO opens on May 14, 2025, while B.D.Industries IPO opens on Jul 30, 2025. The closing date of Accretion Pharmaceuticals IPO and B.D.Industries IPO is May 16, 2025, and Aug 01, 2025, respectively.
| Accretion Pharmaceuticals IPO | B.D.Industries IPO | |
|---|---|---|
| Anchor Bid Date | May 13, 2025 | Jul 29, 2025 |
| Issue Open | May 14, 2025 | Jul 30, 2025 |
| Issue Close | May 16, 2025 | Aug 01, 2025 |
| Basis Of Allotment (Tentative) | May 19, 2025 | Aug 04, 2025 |
| Initiation of Refunds (Tentative) | May 20, 2025 | Aug 05, 2025 |
| Credit of Share (Tentative) | May 20, 2025 | Aug 05, 2025 |
| Listing date (Tentative) | May 21, 2025 | Aug 06, 2025 |
| Anchor Lockin End date 1 | Jun 18, 2025 | Sep 04, 2025 |
| Anchor Lockin End date 2 | Aug 17, 2025 | Nov 03, 2025 |
Accretion Pharmaceuticals IPO P/E ratio is 21.29, as compared to B.D.Industries IPO P/E ratio of 13.27.
| Accretion Pharmaceuticals IPO | B.D.Industries IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)B.D.Industries (Pune) Ltd.'s revenue increased by 52% and profit after tax (PAT) rose by 156% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.48 | 70.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 21.29 | 13.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹112.27 Cr. | ₹153.47 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 72.47 | 43.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.73 | 43.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.52 | 1.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.74 | ₹8.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 72.47 | 35.97 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Accretion Pharmaceuticals IPO Retail Individual Investors (RII) are offered 12,22,800 shares while in B.D.Industries IPO retail investors are offered 12,22,800 shares. Qualified Institutional Buyers (QIB) are offered 1,41,600 shares in Accretion Pharmaceuticals IPO and 7,96,800 shares in B.D.Industries IPO.
| Accretion Pharmaceuticals IPO | B.D.Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | 2,11,200 shares | 11,95,200 shares |
| Market Maker Reservation | 1,47,600 shares | 2,16,000 shares |
| QIB | 1,41,600 shares | 7,96,800 shares |
| NII | 12,22,800 shares | 5,97,600 shares |
| RII | 12,22,800 shares | 13,94,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 27,98,400 shares | 39,84,000 shares |
Accretion Pharmaceuticals IPO subscribed 7.67x in total, whereas B.D.Industries IPO subscribed 1.81x.
| Accretion Pharmaceuticals IPO | B.D.Industries IPO | |
|---|---|---|
| QIB (times) | 12.14x | 1.27x |
| NII (times) | 4.28x | 3.66x |
| Big NII (times) | 5.59x | |
| Small NII (times) | 0.89x | |
| RII (times) | 10.54x | 1.32x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 7.67x | 1.81x |
